Mission

The Oxfendazole Development Group (ODG) is a U.S.-based 501(c)(3) nonprofit organization focused on developing an improved medicine for the treatment of neglected tropical diseases. ODG aims to make any treatments developed accessible to the populations that need them, regardless of profit. The organization is engaged in both preclinical and clinical studies to evaluate the safety and efficacy of oxfendazole, a veterinary deworming medication, for human use against diseases such as trichuriasis.